Chescapmanager’s Acceleron Pharma XLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-20,000
Closed -$3.44M 75
2021
Q3
$3.44M Buy
+20,000
New +$2.62M 0.49% 46

Chescapmanager's XLRN Position: Q4 2021 in Review

Chescapmanager sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 20,000 shares — an estimated $3.44M sold.

Chescapmanager first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $3.44M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Chescapmanager reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Chescapmanager sold 20,000 Acceleron Pharma shares in Q4 2021, an estimated $3.44M.
  • Chescapmanager first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
  • Chescapmanager's Acceleron Pharma position peaked at $3.44M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Chescapmanager's 13F filing for Q4 2021, filed 11 Feb 2022.